| Primary |
| Bipolar Disorder |
30.9% |
| Epilepsy |
24.8% |
| Drug Use For Unknown Indication |
13.5% |
| Product Used For Unknown Indication |
7.5% |
| Depression |
6.7% |
| Convulsion |
3.1% |
| Bipolar I Disorder |
2.6% |
| Insomnia |
2.0% |
| Bipolar Ii Disorder |
1.5% |
| Partial Seizures |
1.4% |
| Anxiety |
1.2% |
| Affective Disorder |
0.8% |
| Hypertension |
0.7% |
| Constipation |
0.5% |
| Complex Partial Seizures |
0.5% |
| Sleep Disorder |
0.5% |
| Contraception |
0.5% |
| Prophylaxis |
0.5% |
| Schizophrenia |
0.4% |
| Migraine |
0.4% |
|
| Rash |
32.8% |
| Stevens-johnson Syndrome |
9.4% |
| Vomiting |
5.4% |
| Convulsion |
4.5% |
| Drug Exposure During Pregnancy |
4.3% |
| Urticaria |
4.1% |
| Tremor |
4.0% |
| Vision Blurred |
3.6% |
| Drug Ineffective |
3.5% |
| Pyrexia |
3.2% |
| Somnolence |
3.1% |
| Rash Generalised |
2.9% |
| Weight Increased |
2.8% |
| Alopecia |
2.7% |
| Pruritus |
2.7% |
| Nausea |
2.6% |
| Weight Decreased |
2.4% |
| Rash Pruritic |
2.1% |
| Suicidal Ideation |
2.0% |
| Suicide Attempt |
2.0% |
|
| Secondary |
| Epilepsy |
26.0% |
| Bipolar Disorder |
14.6% |
| Depression |
13.2% |
| Product Used For Unknown Indication |
10.4% |
| Bipolar I Disorder |
5.6% |
| Convulsion |
5.5% |
| Drug Use For Unknown Indication |
4.5% |
| Insomnia |
3.4% |
| Anxiety |
2.1% |
| Migraine |
2.1% |
| Bipolar Ii Disorder |
1.8% |
| Partial Seizures |
1.5% |
| Multiple Sclerosis |
1.4% |
| Frontal Lobe Epilepsy |
1.3% |
| Schizophrenia |
1.2% |
| Drug Exposure During Pregnancy |
1.2% |
| Foetal Exposure During Pregnancy |
1.2% |
| Sleep Disorder |
1.1% |
| Constipation |
0.9% |
| Grand Mal Convulsion |
0.9% |
|
| Rash |
9.9% |
| Weight Increased |
9.1% |
| Stevens-johnson Syndrome |
8.2% |
| Vomiting |
7.2% |
| White Blood Cell Count Increased |
6.2% |
| Convulsion |
5.9% |
| Overdose |
5.7% |
| Tremor |
4.9% |
| Nausea |
4.4% |
| Toxic Epidermal Necrolysis |
4.3% |
| Premature Labour |
4.2% |
| Pyrexia |
4.2% |
| Somnolence |
3.9% |
| Suicide Attempt |
3.9% |
| Ventricular Septal Defect |
3.3% |
| Rash Generalised |
3.2% |
| Drug Hypersensitivity |
3.1% |
| Status Epilepticus |
3.0% |
| Skin Disorder |
2.9% |
| Suicidal Ideation |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.1% |
| Bipolar Disorder |
14.5% |
| Depression |
11.8% |
| Convulsion |
7.9% |
| Epilepsy |
7.8% |
| Anxiety |
7.1% |
| Drug Use For Unknown Indication |
6.0% |
| Pain |
3.7% |
| Sleep Disorder |
3.6% |
| Hypertension |
2.8% |
| Insomnia |
2.5% |
| Multiple Sclerosis |
2.4% |
| Bipolar I Disorder |
2.3% |
| Complex Partial Seizures |
2.1% |
| Smoking Cessation Therapy |
2.1% |
| Simple Partial Seizures |
1.8% |
| Partial Seizures With Secondary Generalisation |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Asthma |
1.6% |
| Schizophrenia |
1.5% |
|
| Weight Increased |
13.0% |
| Vomiting |
8.8% |
| Convulsion |
8.4% |
| Type 2 Diabetes Mellitus |
7.7% |
| Tremor |
6.0% |
| Suicidal Ideation |
5.9% |
| Weight Decreased |
5.8% |
| Somnolence |
5.4% |
| Drug Ineffective |
5.1% |
| Suicide Attempt |
4.8% |
| Nausea |
4.5% |
| Pain |
3.4% |
| Overdose |
2.9% |
| Vision Blurred |
2.8% |
| Tardive Dyskinesia |
2.8% |
| Insomnia |
2.8% |
| Depression |
2.6% |
| Wrong Technique In Drug Usage Process |
2.6% |
| Off Label Use |
2.4% |
| Pulmonary Embolism |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
17.3% |
| Drug Use For Unknown Indication |
15.2% |
| Epilepsy |
14.9% |
| Bipolar Disorder |
10.5% |
| Depression |
4.0% |
| Convulsion |
3.5% |
| Hypertension |
3.5% |
| Contraception |
3.4% |
| Affect Lability |
3.0% |
| Borderline Personality Disorder |
3.0% |
| Generalised Anxiety Disorder |
3.0% |
| Pain |
2.9% |
| Dementia With Lewy Bodies |
2.5% |
| Post Procedural Infection |
2.5% |
| Affective Disorder |
2.0% |
| Anxiety |
1.9% |
| Smoking Cessation Therapy |
1.9% |
| Sleep Disorder |
1.8% |
| Bipolar I Disorder |
1.6% |
| Hiv Infection |
1.5% |
|
| Somnolence |
15.9% |
| Drug Interaction |
14.5% |
| Grand Mal Convulsion |
9.7% |
| Epilepsy |
8.3% |
| Panic Attack |
8.3% |
| Vomiting |
4.8% |
| Systemic Lupus Erythematosus |
4.1% |
| Metrorrhagia |
3.4% |
| Suicidal Ideation |
3.4% |
| Underdose |
3.4% |
| Headache |
2.8% |
| Rash |
2.8% |
| Sleep Disorder |
2.8% |
| Vaginal Discharge |
2.8% |
| Visual Impairment |
2.8% |
| Abnormal Behaviour |
2.1% |
| Encephalitis |
2.1% |
| Leukopenia |
2.1% |
| Nerve Injury |
2.1% |
| Unintended Pregnancy |
2.1% |
|
